The clinical research interests of Dr. Bedimo include strategies for the optimal management of Drug-Resistant HIV Patients, analysis of metabolic Abnormalities in HIV infected Patients and effect of HCV co-infection. Presently, the latest cutting-edge antiviral therapies are available through expanded access programs, and the interested patients are offered the opportunity to join in national multicenter clinical clinical trials and novel pilot studies being performed locally.  Research is an important part of HIV care, both to learn more about how to treat this infection, and to bring the latest advances to our patients.  Current studies include: